about
Caspase-8 contributes to angiogenesis and chemotherapy resistance in glioblastoma.Enhanced healing of diabetic wounds by topical administration of adipose tissue-derived stromal cells overexpressing stromal-derived factor-1: biodistribution and engraftment analysis by bioluminescent imaging.Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis.Human epicardium-derived cells fuse with high efficiency with skeletal myotubes and differentiate toward the skeletal muscle phenotype: a comparison study with stromal and endothelial cells.Exploring the role of microglia in mood disorders associated with experimental multiple sclerosisAbnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitisInteraction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitisIL-1β dependent cerebellar synaptopathy in a mouse mode of multiple sclerosis.Role of amyloid-β CSF levels in cognitive deficit in MS.Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis.Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosisIgIII (270-280)-fragment-like H2N-DDSDEEN-COOH peptide modulates N-CAM expression via Ca2+-dependent ERK signaling during "in vitro neurogenesis".Identification of a caspase-derived N-terminal tau fragment in cellular and animal Alzheimer's disease models.A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum.Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis.Interleukin-1β promotes long-term potentiation in patients with multiple sclerosis.Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake.Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum.Interleukin-1β alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis.Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis.Linking synaptopathy and gray matter damage in multiple sclerosis.TNF-α-mediated anxiety in a mouse model of multiple sclerosis.Gastric inhibitory polypeptide and its receptor are expressed in the central nervous system and support neuronal survival.Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation.Protein disulfide isomerase as a prosurvival factor in cell therapy for muscular and vascular diseasesInterplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive FunctionsPre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitisGlatiramer Acetate Protects Against Inflammatory Synaptopathy in Experimental Autoimmune EncephalomyelitisTransient Receptor Potential Vanilloid 1 Modulates Central Inflammation in Multiple SclerosisImmunomodulatory Effects of Exercise in Experimental Multiple SclerosisVoluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelinationModeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets ConnectivityPeripheral T cells from multiple sclerosis patients trigger synaptotoxic alterations in central neurons'Prototypical' proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targetingBeyond rehabilitation in MS: Insights from non-invasive brain stimulationCentral Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis
P50
Q33779029-75E25087-BC95-4EA9-BE20-03C0677F03E3Q34158926-07D96471-7490-4BBC-835C-8D4C051E0623Q34565099-77813813-8E81-4A95-B422-DC632ED71588Q34611643-F28EA5B8-8493-4D27-8C00-6C8960930798Q35777988-2C939FB5-5C91-412E-804E-40E397AF3D2FQ36610373-9B6C1E38-FB9F-4EDF-AC35-849B5F15660EQ37228420-163A387D-0062-4160-8D37-10F5A2D05FAFQ38261194-854445BA-A502-4925-B6F8-D9E43DBBA8FAQ38346742-85ED958C-D737-4D7F-B0B5-1243CA077555Q38639337-2354DB2A-8218-47EF-81E5-A17846BC4337Q39448667-1A78B4B4-7721-432E-89A3-D95FBEA14D05Q39969081-8BC7FF5F-6A86-471A-A6BB-60841B010CBEQ39977284-EDDC9222-5944-41B2-A81C-D1827CE0CE89Q41260178-26B98200-4C21-44B4-B41A-3FCAB2468EB3Q46437031-E178FC9D-6980-44FE-A36A-9C3A5BFB1696Q46899417-A19B3922-27D0-4763-B5E1-3E477E4C2C2EQ47211013-2674B3B3-17A0-4A64-B3F2-3233D25E571FQ47812042-5DB73098-BA35-48CE-99FF-F48245C0976CQ47987358-E6CAC1FB-3AD2-4FCE-A78C-284E93896DCAQ48151704-3BA7FF67-3284-4746-B2ED-BDA0C259EF51Q48204687-690B1613-B8A9-4DD5-8F70-EB2C8C70EF1CQ48427603-46ED4800-5E20-4D3E-84EB-880C45FB0A39Q48897563-CD9659E7-21B9-4FD1-8507-44B4FD9B4FDAQ55115006-EE39ADDF-81D3-4EFC-9781-06BC3AD5E529Q58694834-5A03762C-2786-42DC-88AE-E02395DF115AQ58795499-FC8F8463-2173-482F-80C0-57E6C1B74FD0Q60535497-B92DF034-6C25-45A1-A2AB-E58A02AD09C4Q60535501-2685B5D7-AEC1-4116-B00A-70F78421180AQ61807114-7A8DAD1B-6A37-404E-BC7E-F1AF84F60491Q90401535-9678574C-2898-4C16-873F-351899B44F73Q92115169-A57248CE-D724-448F-8C0B-7C923F9FFC16Q92259040-635B12AE-0E51-4F57-B189-B63BB094E727Q92270730-0C9283F5-A410-4E30-AEA3-480AE7365DDEQ92403595-FBC12783-D082-4487-A730-CD03E0A4E0B9Q93009060-74B9E87C-BE42-4130-A9B0-9CB82387233AQ95829364-A37519EB-AEC3-470A-A360-C36F64245CFA
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Antonietta Gentile
@ast
Antonietta Gentile
@en
Antonietta Gentile
@es
Antonietta Gentile
@nl
Antonietta Gentile
@sl
type
label
Antonietta Gentile
@ast
Antonietta Gentile
@en
Antonietta Gentile
@es
Antonietta Gentile
@nl
Antonietta Gentile
@sl
prefLabel
Antonietta Gentile
@ast
Antonietta Gentile
@en
Antonietta Gentile
@es
Antonietta Gentile
@nl
Antonietta Gentile
@sl
P108
P106
P108
P1153
36911830900
P21
P31
P496
0000-0003-2456-0769